SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001193125-18-235020
Filing Date
2018-08-01
Accepted
2018-08-01 16:45:13
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B2 d555235d424b2.htm 424B2 517794
2 GRAPHIC g555235g15a71.jpg GRAPHIC 94190
3 GRAPHIC g555235g17x87.jpg GRAPHIC 38365
4 GRAPHIC g555235g59f95.jpg GRAPHIC 129370
5 GRAPHIC g555235g64x21.jpg GRAPHIC 59450
6 GRAPHIC g555235g75l28.jpg GRAPHIC 59264
7 GRAPHIC g555235g84w19.jpg GRAPHIC 70976
8 GRAPHIC g555235g91a07.jpg GRAPHIC 58938
  Complete submission text file 0001193125-18-235020.txt   1222731
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-208314 | Film No.: 18985359
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1